首页> 美国卫生研究院文献>BMC Gastroenterology >Exclusive enteral nutrition with concomitant early thiopurine use was effective in maintaining steroid-free remission in a Southeast Asian cohort of children with Crohn’s disease
【2h】

Exclusive enteral nutrition with concomitant early thiopurine use was effective in maintaining steroid-free remission in a Southeast Asian cohort of children with Crohn’s disease

机译:独家肠道营养与早期硫代嘌呤同时使用可有效维持东南亚克罗恩病儿童队列中无类固醇的缓解

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundExclusive enteral nutrition (EEN) is as effective as corticosteroids in inducing remission in children with Crohn’s disease (CD). However, over 50% of these children relapse by 12 months of diagnosis. Thiopurines are commonly prescribed as maintenance therapy for CD, but evidence for its efficacy is controversial. Data on the effectiveness of EEN in Southeast Asian (SEA) children with CD is scarce. This study aims to evaluate the efficacy of EEN induction therapy in a cohort of SEA children with newly diagnosed CD. The secondary aim was to evaluate concomitant early azathioprine (EAZ) use in determining remission rate at 6 and 12 months.
机译:背景:独家肠内营养(EEN)与皮质类固醇在诱导克罗恩病(CD)儿童缓解方面一样有效。然而,这些儿童中有50%以上在诊断后12个月内复发。硫嘌呤通常被开列为CD的维持疗法,但其功效的证据尚有争议。 EEN在东南亚(SEA)CD儿童中的有效性数据很少。这项研究的目的是评估EEN诱导疗法在一批新诊断CD的SEA儿童中的疗效。次要目的是评估同时使用早期硫唑嘌呤(EAZ)来确定6个月和12个月时的缓解率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号